Lithium is neuroprotective in preclinical racing models. In addition to this, posttroke neurorgeneration is stimulated during the transplant of messenchymal stem cells (MSCS). The preconditioning of MSCs with lithium further improves the potential of neuroregenerator of MSCs, which act by drying extracellular vesicles (EVS). The current work analyzed, whether it is preconditioning the lithium modifies the schemes of EV secretion, improving the therapeutic potential of such derived EVS (Li-EVS) compared to the EVS enriched from MSC natives. Indeed, LI-EVS has significantly improved the resistance of cultivated astrocytes, microgliums and neurons against hypoxic injury compared to the controls and cells treated with Aboriginal EV.
The use of a race mouse model, the intravenous delivery of Li-EVS has increased neurological recovery and neuro-generation for 3 months compared to the controls and mice treated with EV, although the latter has also shown A significantly better behavioral test performance compared to controls. The preconditioning of MSCs with lithium has also modified the secretion models of such EVS, modifying the contents of various mirnas within these vesicles. As such, LI-EVS displayed significantly increases MIR-1906 levels, which proved to be a new regulator for the toll type receiver 4 (TLR4). LI-EVS reduces the abundance of posthypoxic and postish TLR4, resulting in a nuclear factor inhibition Kappa-chain-valorization of the signal path B (NF-κB), a reduced protestive activity and decreased both inducible, not Synthase and cyclooxygenase- 2 expression, which lead to reduced levels of poststretral brain inflammation.
Concusted, this study for the first time testifies to improved therapeutic potential of Li-EVS with respect to native vehicles, interfering with a new signaling channel that allows both acute neuroprotection an improved neurological recovery.
Toll receiver 9 Cancer Agonists
The toll receiver 9 (TLR9) is a model recognition receiver which is mainly intracellular located in immune cells, including dendritic cells, macrophages, natural killer cells and other antigen presenters (APCs). Primary ligands for TLR9 receptors are oligodinucleotides of non-methylated cytienin phosphate guanosin (GICs). TLR9 agonists induce inflammatory processes that cause improved absorption and killing of microorganisms and cancer cells and the generation of adaptive immune responses.
Preclinical studies on TLR9 agonists suggested efficiently in monotherapy and in association with several agents, which led to clinical trials in advanced cancer patients. In these studies, intravenous, intratumoral and subcutaneous routes of administration have been tested; With anti-tumor responses in the metastatic sites treated and untreated. The TLR9 agonist monotherapy is safe, although the effectiveness is minimal in patients with advanced cancer; Conversely, the combinations seem more promising. Several phase I and II clinical trials in progress evaluate TLR9 agonists associated with a variety of agents, including chemotherapy, radiotherapy, targeted therapy and immunotherapy agents.
In this revision article, we describe the distribution, structure and signaling of TLR9; discuss the results of the preclinical studies of TLR9 agonists; and examine the ongoing clinical trials of TLR9 agonists individually and combined in patients with advanced solid tumors. The temperature of the water has a major influence on the host innate immune defense and the infectivity of pathogens in ectothermal telebs. The toll (TLR) receptors are the first innate and well-characterized interior receptors that are kept in vertebrates. However, little information is known about the effect of temperature variation on TLRs in fish species. In this study, we used adult zebrafish as a search model to study the effect of the water temperature on the TLR.
Lithium modulates miR-1906 levels of mesenchymal stem cell-derived extracellular vesicles contributing to poststroke neuroprotection by toll-like receptor 4 regulation
Typing type 2/4 receptor inhibitors can reduce premature birth in mice
Objectives: Premature birth (PTB) occurs in 5% to 18% of newborns. However, the underlying inflammatory mechanisms have not been elucidated.
Methods: We have created a mouse model of a PTB associated with infections. Physical panels in pregnant mice with or without lipopolysaccharide treatment (LPS) were observed and the toll (TLR) toll (TLR) CD11B + cell frequencies are analyzed. Cytokine levels in plasma and pathological changes have been evaluated after LPS processing. A rescue experience was used to put potential immunological mechanisms underlying the PTB.
Results: The infiltration of lymphocytes could be observed in the mouse placentas following intrauterine injection with LPS. The percentage of inflammatory cells decreased 12 hours after treatment. In addition, the TLR2 and TLR4 expression in peripheral blood cells increased considerably 4 hours after intraperitoneal LPS injection. The maximum expression TLR2 and TLR4 in the peripheral blood cells occurred 8 hours after treatment. TLR4 and TLR-2/4 inhibitors reduced interleukin-10 levels, interferon-γ and tumor-α necrosis in peripheral blood and deferred PTB.
Conclusions: The TLR2 and TLR4 inhibition could play important roles in the PTB.
Description: This monoclonal antibody enables sensitive and specific detection of mouse IL-12/-23 (p40) in immunoassays such as ELISA and ELISpot. The antibody is specific for the p40 subunit of IL-12 and IL-23.
Description: This monoclonal antibody is recommended for neutralization of mouse IL-12/-23 (p40) bioactivity. The antibody is specific for the p40 subunit of IL-12 and IL-23.
Description: This monoclonal antibody enables sensitive and specific detection of mouse IL-12/-23 (p40) in immunoassays such as ELISA and ELISpot. The antibody is specific for the p40 subunit of IL-12 and IL-23.
Description: This monoclonal antibody enables sensitive and specific detection of mouse IL-12 (p70) in immunoassays such as ELISA and ELISpot. The antibody is specific for the p40 subunit of IL-12 and IL-23.
Description: Quantitativesandwich ELISA kit for measuring Mouse Interleukin 23, IL-23 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.
Description: Quantitativesandwich ELISA kit for measuring Mouse Interleukin 23, IL-23 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.
Description: IL-23 Antibody: Like interleukin-27 (IL-27), IL-23 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the IL-12p40 subunit and a novel p19 subunit. IL-23 is secreted by activated dendritic cells, macrophages, and monocytes. Its biological activities include enhancing the proliferation of memory T cells and the production of IFN-gamma, IL-12, and TNF-α from activated T cells, and can stimulate macrophages to produce TNF-α and nitric oxide. It has also been shown to possess potent anti-tumor and anti-metastatic activity in mouse models of cancer, suggesting a potential role for IL-23 in therapeutic treatment of cancer.
Description: IL-23 Antibody: Like interleukin-27 (IL-27), IL-23 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the IL-12p40 subunit and a novel p19 subunit. IL-23 is secreted by activated dendritic cells, macrophages, and monocytes. Its biological activities include enhancing the proliferation of memory T cells and the production of IFN-gamma, IL-12, and TNF-α from activated T cells, and can stimulate macrophages to produce TNF-α and nitric oxide. It has also been shown to possess potent anti-tumor and anti-metastatic activity in mouse models of cancer, suggesting a potential role for IL-23 in therapeutic treatment of cancer.
Description: IL-23 Antibody: Like interleukin-27 (IL-27), IL-23 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the IL-12p40 subunit and a novel p19 subunit. IL-23 is secreted by activated dendritic cells, macrophages, and monocytes. Its biological activities include enhancing the proliferation of memory T cells and the production of IFN-gamma, IL-12, and TNF-α from activated T cells, and can stimulate macrophages to produce TNF-α and nitric oxide. It has also been shown to possess potent anti-tumor and anti-metastatic activity in mouse models of cancer, suggesting a potential role for IL-23 in therapeutic treatment of cancer.
Description: IL-23 Antibody: Like interleukin-27 (IL-27), IL-23 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the IL-12p40 subunit and a novel p19 subunit. IL-23 is secreted by activated dendritic cells, macrophages, and monocytes. Its biological activities include enhancing the proliferation of memory T cells and the production of IFN-gamma, IL-12, and TNF-α from activated T cells, and can stimulate macrophages to produce TNF-α and nitric oxide. It has also been shown to possess potent anti-tumor and anti-metastatic activity in mouse models of cancer, suggesting a potential role for IL-23 in therapeutic treatment of cancer.
Description: This monoclonal antibody is recommended for neutralization of human IL-23 bioactivity. The antibody is specific for the p19 subunit of IL-23.
Description: This monoclonal antibody enables sensitive and specific detection of human IL-23 in immunoassays such as ELISA and ELISpot. The antibody is specific for the p19 subunit of IL-23.
Description: Description of target: Interleukin-23 subunit alpha(IL-23) is a protein that in humans is encoded by the IL23A gene. IL-23 is a heterodimeric cytokine consisting of two subunits, one called p40, which is shared with another cytokine, IL-12, and another called p19 (the IL-23 alpha subunit). IL-23 is an important part of the inflammatory response against infection. It promotes upregulation of the matrix metalloprotease MMP9, increases angiogenesis and reduces CD8+ T-cell infiltration. Recently, IL-23 has been implicated in the development of cancerous tumors. The International Radiation Hybrid Mapping Consortium mapped the p19 gene to chromosome 12 (stSG47812).;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 2 pg/ml
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse IL-23 in samples from serum, plasma, tissue homogenates and other biological fluids.
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin-23 receptor (IL-23R) in samples from serum, plasma, tissue homogenates, urine. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin-23 receptor (IL-23R) in samples from serum, plasma, tissue homogenates, urine. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.
Description: IL-23 is a proinflammatory heterodimeric protein composed of two subunits, a unique p19 subunit and a p40 subunit, which is shared with IL-12. IL-23 is secreted by activated dendritic cells and macrophages, and signals though a receptor comprised of IL-23R complexed with IL-12Rβ2. IL-23 has been shown to enhance proliferation of memory T cells. It also stimulates the production of IFN-gamma in NK cells, induces IL-17 production, and drives Th17 mediated responses. Recombinant IL-23 is a 53.5 kDa heterodimeric protein consisting of two subunits, p19 (170 amino acids) and p40 (306 amino acids).*Manufactured using BTI-Tn-5B1-4 cells under license from the Boyce Thompson Institute for Plant Research, Inc.
Description: IL-23 is a proinflammatory heterodimeric protein composed of two subunits, a unique p19 subunit and a p40 subunit, which is shared with IL-12. IL-23 is secreted by activated dendritic cells and macrophages, and signals though a receptor comprised of IL-23R complexed with IL-12Rβ2. IL-23 has been shown to enhance proliferation of memory T cells. It also stimulates the production of IFN-gamma in NK cells, induces IL-17 production, and drives Th17 mediated responses. Recombinant IL-23 is a 53.5 kDa heterodimeric protein consisting of two subunits, p19 (170 amino acids) and p40 (306 amino acids).*Manufactured using BTI-Tn-5B1-4 cells under license from the Boyce Thompson Institute for Plant Research, Inc.
Description: Interleukin-23 (IL-23) is a heterodimeric cytokine composed of two disulfide-linked subunits, a p19 subunit that is unique to IL-23, and a p40 subunit that is shared with IL-12 (1-5). Although p19 is expressed by activated macrophages, dendritic cells, T cells, and endothelial cells, only activated macrophages and dendritic cells express p40 concurrently to produce IL-23. The functional IL-23 receptor complex consists of two receptor subunits, the IL-12 receptor beta 1 subunit (IL-12 Rbeta1) and the IL-23-specific receptor subunit (IL-23 R). IL-23 has biological activities that are similar to, but distinct from IL-12. Both IL-12 and IL-23 induce proliferation and IFN-gamma production by human T cells. While IL-12 acts on both naie and memory human T cells, the effects of IL-23 is restricted to memory T cells. In mouse, IL-23 but not IL-12, has also been shown to induce memory T cells to secret IL-17, a potent proinflammatory cytokine. IL-12 and IL-23 can induce IL-12 production from mouse splenic DC of both the CD8-and CD8+ subtypes, however only IL-23 can act directly on CD8+ DC to mediate immunogenic presentation of poorly immunogenic tumor/self peptide.
Description: Interleukin 23 (IL-23) is a heterodimeric cytokine composed of two disulfide-linked subunits, a p19 subunit that is unique to IL-23, and a p40 subunit that is shared with IL-12. The p19 subunit has homology to the p35 subunit of IL-12, as well as to other single chain cytokines such as IL-6 and IL-11. The p40 subunit is homologous to the extracellular domains of the hematopoietic cytokine receptors. Although p19 is expressed by activated macrophages, dendritic cells, T cells, and endothelial cells, only activated macrophages and dendritic cells express p40 concurrently to produce IL-23. IL-23 has biological activities that are similar to, but distinct from IL-12. Both IL-12 and IL-23 induce proliferation and IFN-gamma production by human T cells. While IL-12 acts on both naive and memory human T cells, the effects of IL-23 is restricted to memory T cells.
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-23 . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-23 . This antibody is tested and proven to work in the following applications:
Description: This monoclonal antibody is recommended for neutralization of human IL-12/-23 (p40) bioactivity. The antibody is specific for the p40 subunit of IL-12 and IL-23.
Description: These monoclonal antibodies are specific for the p40 subunit of IL-12 and IL-23. Combine with different detection antibodies for sensitive and specific detection of human IL-12 (p70), IL-12/-23 (p40) and IL-23.
Description: This monoclonal antibody enables sensitive and specific detection of human IL-12/-23 (p40) in immunoassays such as ELISA and ELISpot. The antibody is specific for the p40 subunit of IL-12 and IL-23.
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin 23, IL-23 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin 23, IL-23 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.
Description: Quantitativesandwich ELISA kit for measuring Rat Interleukin 23, IL-23 in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.
Description: Quantitativesandwich ELISA kit for measuring Rat Interleukin 23, IL-23 in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.
Description: IL-23 Human Recombinant produced in HEK cells is a 55kDa heterodimeric protein composed of 2 disulfide-linked subunits - 19kDa (p19) and 43 kDa (p40).
Description: Quantitative sandwich ELISA for measuring Rat Interleukin-23 (IL-23) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
Description: Quantitative sandwich ELISA for measuring Rat Interleukin-23 (IL-23) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
Description: Quantitative sandwich ELISA for measuring Rat Interleukin-23 (IL-23) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
Description: Interleukin 23 receptor (IL-23R) is a type I cytokine receptor, and IL-23R pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. Also, IL-23R associates constitutively with Janus kinase 2 (JAK2), and binds to transcription activator STAT3 in a ligand-dependent manner. Furthermore, IL-23R mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. As for IL-23, it may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis.
Description: Interleukin 23 receptor (IL-23R) is a type I cytokine receptor, and IL-23R pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. Also, IL-23R associates constitutively with Janus kinase 2 (JAK2), and binds to transcription activator STAT3 in a ligand-dependent manner. Furthermore, IL-23R mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. As for IL-23, it may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis.
Description: IL-23 is a proinflammatory heterodimeric protein composed of two subunits, a unique p19 subunit and a p40 subunit, which is shared with IL-12. IL-23 is secreted by activated dendritic cells and macrophages, and signals though a receptor comprised of IL-23R complexed with IL-12Rβ2. IL-23 has been shown to enhance proliferation of memory T cells. It also stimulates the production of IFN-γ in NK cells, induces IL-17 production, and drives Th17 mediated responses. Recombinant IL-23 is a 53.5 kDa heterodimeric protein consisting of two subunits, p19 (170 amino acids) and p40 (306 amino acids).*Manufactured using BTI-Tn-5B1-4 cells under license from the Boyce Thompson Institute for Plant Research, Inc.
Description: anti-CD25 IL-2 receptor expressed on activated T and B cells
×
The encapsulation of pancreatic islands in alginate microcapsules is used to reduce or avoid the application of immunosuppression of life to life in the prevention of rejection. However, the long-term graft function is limited due to varying degrees of host tissue responses against capsules. Inflammatory responses caused by inflammatory responses caused by biomaterials and molecular grounds related to danger (wet) derived from islands (wet). This document reports on a new strategy for engineering alginate microcapsules with immunomodulatory polymer pectin with varying degrees of methyl esterification (DM) to reduce these host tissue responses.
Antibodies | Assay Kits | Biology Cells | cDNA | Clia Kits | Culture Cells | Devices | DNA Templates | DNA Testing | Elisa Kits | Enzymes | Gels | Medium & Serums | NATtrol | Particles | PCR | Peptides | Reagents | Recombinant Proteins | Ria Kits | RNA | Test Kits | Vector & Virus 
Antibodies | Assay Kits | Biology Cells | cDNA | Clia Kits | Culture Cells | DNA | DNA Templates | DNA Testing | Elisa Kits | Equipments | Gels | Medium & Serums | NATtrol | PCR | Peptides | Recombinant Proteins | Ria Kits | RNA | Test Kits | Vector & Virus | Western Blot 
Antibodies | Assay Kits | Biology Cells | cDNA | Clia Kits | Devices | DNA | DNA Testing | Elisa Kits | Equipments | Medium & Serums | NATtrol | Particles | Peptides | Recombinant Proteins | Ria Kits | RNA | Vector & Virus | Western Blot 
Antibodies | Assay Kits | Biology Cells | cDNA | Clia Kits | Culture Cells | DNA | DNA Templates | DNA Testing | Enzymes | Equipments | Gels | NATtrol | Particles | PCR | Peptides | Recombinant Proteins | Ria Kits | Test Kits | Vector & Virus | Western Blot
No Comment